Unrelated Donor Transplant vs Immune Therapy for Pediatric Aplastic Anemia | Aplastic Anemia & MDS International Foundation

Unrelated Donor Transplant vs Immune Therapy for Pediatric Aplastic Anemia

Presenter(s): 
Topic(s): 
Aplastic Anemia
Presentation Date: 
Monday, June 8, 2020

Due to internet connectivity issues, the audio for this webinar will be rerecorded as soon as the speaker is available. In the interim, please accept our apologies for the quality of the sound. We are attached a PDF of the presentation for your review although we note that the video quality was acceptable. 

Timothy S. Olson, MD, PhD, is an Attending Physician with Children's Hospital of Philadelphia where he serves as the Medical Director of the Blood and Bone Marrow Transplant Program and as Director of Research for the Comprehensive Bone Marrow Failure Center.  Dr. Olson is also an Assistant Professor of Pediatrics at the Perelman School of Medicine at The University of Pennsylvania.  Dr. Olson focuses on pediatric hematopoietic stem cell transplantation (HSCT), with a specific emphasis on HSCT for patients with inherited and acquired bone marrow failure.